New Jersey-based mother Lauren Spiezia, 33, completed the grueling race topless to raise awareness for breast cancer after ...

Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) (Actinium or the Company), a pioneer in differentiated targeted radiotherapies with the potential to transform cancer treatment, today announced th ...

Frontier has received FDA allowance to proceed to human clinical trials under an Investigational New Drug (IND) application ...

Late-breaking oral presentation to highlight efficacy data across tumor types and in the ovarian cancer primary analysis populationPRINCETON, N.J., Nov. 04, 2026 (GLOBE NEWSWIRE) -- (“PMV Pharma” or ...

Data shows positive one-year safety and efficacy data from three patients enrolled in ongoing Phase 2 clinical trial being led by researchers at ...

张学癌症本质上是一类基因病。首先，要理解“遗传学”这个词的由来。1905年，英国剑桥大学的威廉·贝特森（William ...

It is easy to dismiss a mole on the skin as nothing to worry about. But if it changes shape or color or grows larger than ...

Laboratoires Pierre Fabre Singapore is delighted to announce the access for patients to BRAFTOVI® (encorafenib) in ...

An experimental vaccine against pancreatic cancer activated the immune systems of 98.9% of patients evaluated in a Phase 2 ...

Frontier Medicines Corporation (Frontier), a clinical-stage, AI-powered precision medicines company that discovers and develops covalent medicines for previously undruggable and hard-to-drug ...

CAR-T cell therapy is a form of cancer immunotherapy that uses genetically modified immune cells to recognize and attack cancer. Doctors collect a patient’s T cells and engineer them to produce ...

Laboratoires Pierre Fabre announces the approval of BRAFTOVI® (encorafenib) in combination with MEKTOVI® (binimetinib) for ...